| Business Summary | | Strategic
Diagnostics
Inc.
(SDI)
develops,
manufactures
and
markets
immunoassay-based
test
kits
for
rapid
and
inexpensive
detection
of
a
wide
variety
of
substances
in
the
food
safety
and
water
quality
markets.
Through
its
Strategic
BioSolutions
division,
SDI
also
provides
antibody
and
immunoreagent
research
and
development
production
services.
The
Company
is
a
recognized
leader
in
the
field
of
immunoassay
research,
development
and
manufacturing
and
develops
products
in
markets
where
the
attributes
of
immunoassay
technology
(i.e.
speed,
ease-of-use,
cost-effectiveness,
quantitation,
and
flexibility),
meet
specific
customer
needs.
In
addition
to
products
serving
the
two
primary
markets,
the
Company
develops,
manufactures,
and
sells
immunoassay
test
kits
for
medical
applications. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | SDIX
develops,
manufactures
and
markets
immunoassay
based
test
kits
for
rapid
detection
of
substances
in
three
primary
markets:
water
quality,
industrial
testing
and
agricultural.
For
the
six
months
ended
6/30/01,
revenues
rose
23%
to
$14.3
million.
Net
income
rose
75%
to
$994
thousand.
Revenues
reflect
higher
food
safety
product
sales.
Higher
income
also
reflects
lower
research
and
development
expenses
and
decreased
SG&A
expenses
as
a
percentage
of
sales. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Grover Wrenn, 58 Chairman | -- | -- | Richard Birkmeyer, 47 Pres,
CEO | $233K | -- | Arthur Koch, Jr., 47 COO,
VP-Fin. | 213K | -- | Martha Reider, 46 VP
of HR and Quality Assurance, Sec. | 155K | -- | James Stave, Ph.D., 46 VP
of R&D | 161K | $25K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|